Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Observed a minor administrative update (new last update date) with no substantive changes to study design, primary/secondary outcomes, eligibility criteria, or participating locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:03:48.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T05:23:15.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Page updates version from v3.0.2 to v3.1.0 and removes a specific disease resource; otherwise, core content remains unchanged.
    Difference
    0.4%
    Check dated 2025-09-29T03:01:05.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated to revision v3.0.2 and removed the Back to Top link; no substantive changes to core content or pricing.
    Difference
    0.1%
    Check dated 2025-09-14T19:00:57.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T14:40:17.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated to include new resources related to head and neck cancer, specifically mentioning pembrolizumab and various related medical topics, while removing some previous location and resource details.
    Difference
    4%
    Check dated 2025-08-31T11:45:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.